Oleg Tsodikov

Oleg Tsodikov

University of Kentucky

H-index: 40

North America-United States

About Oleg Tsodikov

Oleg Tsodikov, With an exceptional h-index of 40 and a recent h-index of 23 (since 2020), a distinguished researcher at University of Kentucky, specializes in the field of Structural biology, enzymology, antibacterial drug discovery, DNA replication, transcription.

His recent articles reflect a diverse array of research interests and contributions to the field:

Targeting thiol isomerase activity with zafirlukast to treat ovarian cancer from the bench to clinic (vol 37, e022914, 2023)

Discovery and development of novel substituted monohydrazides as potent antifungal agents

Aromatic hydrazides: A potential solution for Acinetobacter baumannii infections

Identification and analysis of small molecule inhibitors of FosB from Staphylococcus aureus

Mithplatins: Mithramycin SA‐Pt (II) Complex Conjugates for the Treatment of Platinum‐Resistant Ovarian Cancers

of print.

Discovery and mechanistic analysis of structurally diverse inhibitors of acetyltransferase Eis among FDA-approved drugs

Discovery and development of inhibitors of acetyltransferase Eis to combat Mycobacterium tuberculosis.

Oleg Tsodikov Information

University

Position

Professor of Pharmaceutical Sciences

Citations(all)

4946

Citations(since 2020)

1573

Cited By

4038

hIndex(all)

40

hIndex(since 2020)

23

i10Index(all)

76

i10Index(since 2020)

55

Email

University Profile Page

University of Kentucky

Google Scholar

View Google Scholar Profile

Oleg Tsodikov Skills & Research Interests

Structural biology

enzymology

antibacterial drug discovery

DNA replication

transcription

Top articles of Oleg Tsodikov

Title

Journal

Author(s)

Publication Date

Targeting thiol isomerase activity with zafirlukast to treat ovarian cancer from the bench to clinic (vol 37, e022914, 2023)

Justine A Gelzinis

Melanie K Szahaj

Roelof H Bekendam

Sienna E Wurl

Megan M Pantos

...

2023/5

Discovery and development of novel substituted monohydrazides as potent antifungal agents

RSC Medicinal Chemistry

Nishad Thamban Chandrika

Keith D Green

Abbygail C Spencer

Oleg V Tsodikov

Sylvie Garneau-Tsodikova

2023

Aromatic hydrazides: A potential solution for Acinetobacter baumannii infections

European Journal of Medicinal Chemistry

Keith D Green

Nishad Thamban Chandrika

Loan Y Vu

Allan H Pang

Oleg V Tsodikov

...

2023/3/5

Identification and analysis of small molecule inhibitors of FosB from Staphylococcus aureus

RSC Medicinal Chemistry

Skye Travis

Keith D Green

Nishad Thamban Chandrika

Allan H Pang

Patrick A Frantom

...

2023

Mithplatins: Mithramycin SA‐Pt (II) Complex Conjugates for the Treatment of Platinum‐Resistant Ovarian Cancers

ChemMedChem

Suhas S Bhosale

Abhisek Mandal

Caixia Hou

J Robert McCorkle

David Schweer

...

2023/2/1

of print.

Biochemistry

AH Pang

KD Green

A Punetha

N Thamban Chandrika

KC Howard

...

2023/1/19

Discovery and mechanistic analysis of structurally diverse inhibitors of acetyltransferase Eis among FDA-approved drugs

Biochemistry

Allan H Pang

Keith D Green

Ankita Punetha

Nishad Thamban Chandrika

Kaitlind C Howard

...

2023/1/19

Discovery and development of inhibitors of acetyltransferase Eis to combat Mycobacterium tuberculosis.

Methods in Enzymology

Allan H Pang

Keith D Green

Oleg V Tsodikov

Sylvie Garneau-Tsodikova

2023/7/27

Structural insights into the diverse prenylating capabilities of DMATS prenyltransferases

Evan T Miller

Oleg V Tsodikov

Sylvie Garneau-Tsodikova

2023

Mithramycin derivatives having increased selectivity and anti-cancer activity

2023/7/4

Discovery and Optimization of 6-(1-Substituted pyrrole-2-yl)-s-triazine Containing Compounds as Antibacterial Agents

ACS Infectious Diseases

Keith D Green

Allan H Pang

Nishad Thamban Chandrika

Atefeh Garzan

Anthony D Baughn

...

2022/3/3

Inhibition of Fosfomycin Resistance Protein FosB from Gram-Positive Pathogens by Phosphonoformate

Biochemistry

Skye Travis

Keith D Green

Nathaniel C Gilbert

Oleg V Tsodikov

Sylvie Garneau-Tsodikova

...

2022/12/16

A Colorimetric Assay to Identify and Characterize Bacterial Primase Inhibitors

Allan H Pang

Oleg V Tsodikov

2022/11/30

Discovery of substituted benzyloxy-benzylamine inhibitors of acetyltransferase Eis and their anti-mycobacterial activity

European journal of medicinal chemistry

Allan H Pang

Keith D Green

Nishad Thamban Chandrika

Atefeh Garzan

Ankita Punetha

...

2022/11/15

Structure-based design of haloperidol analogues as inhibitors of acetyltransferase Eis from Mycobact

RSC Med. Chem.

Ankita Punetha

Keith D Green

Atefeh Garzan

Nishad Thamban Chandrika

Melisa J Willby

...

2021/1/1

EPV001/# 119 Screening and identification of novel chemotherapy agents in platinum-resistant ovarian cancer

D Schweer

J Mccorkle

J Rohr

O Tsodikov

F Ueland

...

2021/11/1

Development of Single‐Stranded DNA Bisintercalating Inhibitors of Primase DnaG as Antibiotics

ChemMedChem

Keith D Green

Ankita Punetha

Nishad Thamban Chandrika

Caixia Hou

Sylvie Garneau‐Tsodikova

...

2021/6/17

Allosteric interference in oncogenic FLI1 and ERG transactions by mithramycins

Structure

Caixia Hou

Abhisek Mandal

Jürgen Rohr

Oleg V Tsodikov

2021/5/6

Mithramycin and analogs for overcoming cisplatin resistance in ovarian cancer

David Schweer

J Robert McCorkle

Jurgen Rohr

Oleg V Tsodikov

Frederick Ueland

...

2021/1/12

Abstract A41: Novel mithramycin analogues with improved pharmacologic profile and efficacy in ETS transcription factor-driven tumors

Cancer Research

Markos Leggas

Joseph Eckenrode

Yang Liu

Abhisek Mandal

Reiya Hayden

...

2020/7/15

See List of Professors in Oleg Tsodikov University(University of Kentucky)

Co-Authors

H-index: 66
Jurgen Rohr

Jurgen Rohr

University of Kentucky

H-index: 49
Sylvie Garneau-Tsodikova

Sylvie Garneau-Tsodikova

University of Kentucky

H-index: 47
John M. Pascal

John M. Pascal

Université de Montréal

H-index: 23
Wenjing Chen

Wenjing Chen

University of Michigan-Dearborn

academic-engine